Project Grant R21MH133239
- Grant Award Summary The National Institute of Mental Health (NIMH) awarded University of California, Davis $794,931 under the Mental Health Research Grants program (CFDA 93.242) to conduct a five-year longitudinal research project examining early dyadic synchrony and middle childhood outcomes among infants at genetic risk for Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD). The project leverages three prospective longitudinal cohorts of at-risk infants to...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $395,009 to the University of California, Davis on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853). The two-year project, extending through July 31, 2027, supports foundational research to develop antisense oligonucleotide (ASO) therapy for ADNP syndrome (Helsmoortel-van der Aa syndrome), a severe...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $489,500 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to conduct research on identifying early neurobiological markers and developmental factors that impact language acquisition in children with autism spectrum disorder (ASD). The research aims to (1) characterize resting state EEG differences...
- Federal Project Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded UCLA a $625,859 Project Grant effective January 27, 2026, through the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program to develop and validate objective, quantitative measures of infant motor function as predictive biomarkers for Autism Spectrum Disorder (ASD). The research leverages wearable sensor technology and advanced computational...
- This $228,420 Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) supports a five-year research initiative (August 1, 2025 through July 31, 2030) at Stanford University to investigate genetic pathways associated with neurodevelopmental outcomes in children exposed to anti-seizure medications (ASMs) in utero. The research will identify genetic variants in...
- This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $322,000.00 to Case Western Reserve University to perform the following: Analyze electroencephalographic (EEG) and plasma Alzheimer's disease (AD) biomarker data collected during a previous clinical trial studying the effects of the drug memantine on adolescents and young adults with Down syndrome. The analysis will examine the...
- This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $746,183 to the University of South Carolina to conduct a prospective, longitudinal study on the link between preterm infants' autonomic nervous system (ANS) dysfunction and the development of autism spectrum disorder (ASD) and other neurodevelopmental impairments (NDIs). The study aims to: 1) evaluate preterm ANS dysfunction as an...
- The federal Cooperative Agreement award U01HD116463, titled "The Infant Down Syndrome Brain and Behavior Study", is funded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310). The $2,927,457 award will support a longitudinal study to collect multimodal neuroimaging, cognitive/behavioral data, and social communication measures in a cohort of 100 infants with Down syndrome and 50 typically developing controls. The study aims to...
- This $174,788 National Science Foundation (NSF) award under the Computer and Information Science and Engineering (CISE) program focuses on enhancing the assessment and diagnosis of Attention Deficit Hyperactivity Disorder (ADHD). The project aims to develop computational approaches to collect and analyze ADHD-related data, leveraging technologies such as inertial movement units, touch-sensitive screens, and high-precision cameras to gather insights into hyperactivity behaviors. The goal is to...
- Federal Project Grant Award Summary Cincinnati Children's Hospital Medical Center received a $900,000 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 18, 2025, through August 31, 2030. The award supports mechanistic and translational medicine research focused on understanding brain neurophysiology and phenotypic...
MULTIFACTORIAL DYNAMIC MODELING OF BRAIN ASYMMETRY IN NEURODEVELOPMENTAL DISORDERS - PROJECT SUMMARY/ABSTRACT NEURODEVELOPMENTAL DISORDERS (NDDS) COMPRISE OF A GROUP OF DISORDERS ASSOCIATED WITH ABNORMAL BRAIN DEVELOPMENT, LEADING TO ABNORMAL BRAIN FUNCTION OF LANGUAGE, MOTOR, BEHAVIOR, MEMORY AND LEARNING. NDDS, E.G., ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD), AUTISM SPECTRUM DISORDER (ASD) AND INTELLECTUAL DISABILITY, AFFECT APPROXIMATELY 15% OF CHILDREN IN THE UNITED STATES AND POSE A SIGNIFICANT PUBLIC HEALTH BURDEN ON SOCIETY. THE CAUSES OF NDDS ARE STILL LARGELY UNKNOWN. A GROWING BODY OF EVIDENCE SUPPORT THAT MOST NDDS ARE RESULT FROM A COMBINATION OF GENETIC, BIOLOGICAL, PSYCHOSOCIAL AND ENVIRONMENTAL RISK FACTORS RATHER THAN ANY SINGLE ORIGIN. FURTHERMORE, THERE ARE HIGH RATES OF CO-OCCURRENCE BETWEEN DIFFERENT NDDS, AS WELL AS SIMILARITIES IN FUNCTIONAL IMPAIRMENT AND CLINICAL FEATURES, WHICH MAKE THE DIAGNOSIS AND TREATMENT OF NDDS DIFFICULT. HEMISPHERIC ASYMMETRY IS A CORE ELEMENT OF THE BRAIN'S USUAL ORGANIZATION REQUIRED FOR OPTIMAL FUNCTIONING AND A KEY LANDMARK OF BRAIN DEVELOPMENT. WE HAVE RECENTLY REVEALED THAT BRAIN ASYMMETRY IS CLOSELY ASSOCIATED WITH NDDS AND THEIR GENETIC/ENVIRONMENTAL RISK FACTORS AND CLINICAL FEATURES, THOUGH THE CAUSAL INTERACTING RELATIONSHIPS ARE UNCLEAR. HERE WE HYPOTHESIZE THAT THE BIOLOGICAL PROCESS OF BRAIN ASYMMETRY DEVELOPMENT IS INFLUENCED BY COMPLEX GENETIC AND ENVIRONMENTAL CONTRIBUTORS FOR NDDS, AND DIFFERENT DYSREGULATIONS OF THIS MULTIFACTORIAL DYNAMIC SYSTEM MAY MEDIATE THE EMERGENCE OF DIFFERENT CLINICAL SYMPTOMS/BEHAVIORS IN NDDS. PREVIOUS STUDIES OF BRAIN ASYMMETRY IN NDDS ARE LIMITED BY THE CASE-CONTROL AND CROSS-SECTIONAL STUDY DESIGNS, AND THE FACTORS CONTRIBUTING TO NDDS HAVE YET TO BE STUDIED USING AN INTEGRATIVE METHOD. THIS PROPOSAL SEEKS TO OVERCOME THE LIMITATIONS OF PREVIOUS STUDIES BY APPLYING OUR NOVEL INTEGRATIVE ANALYTIC ALGORITHMS AND A TRANSDIAGNOSTIC APPROACH TO SEVERAL EXISTING PUBLIC AND INTERNAL LONGITUDINAL (AND CROSS-SECTIONAL) DATASETS (TOTAL N~16,000), WHICH ARE DESIGNED FOR STUDYING BRAIN DEVELOPMENT AND RELATED HEALTH ISSUES AND COMPRISE EXTENSIVE DATA OF DEMOGRAPHICS, MEDICAL RECORDS, BEHAVIORAL/CLINICAL ASSESSMENTS, COGNITIVE TESTS, GENETICS, AND MULTIMODAL BRAIN IMAGING. THE PROPOSED ANALYSES SEEK TO ADDRESS THE FOLLOWING AIMS: 1) MODEL THE DEVELOPMENTAL MECHANISMS OF BRAIN ASYMMETRY INVOLVING SPATIOTEMPORAL INTERACTIONS BETWEEN MULTIMODAL BRAIN ASYMMETRY COMPONENTS, GENETIC AND ENVIRONMENTAL INFLUENCES AND THIS SYSTEM'S IMPACT ON CHILDREN BEHAVIOR/COGNITION IN TYPICALLY AND ATYPICALLY DEVELOPING CHILDREN AND ADOLESCENTS OVER TIME, AND 2) CHARACTERIZE WITHIN-DIAGNOSES TRAJECTORIES AND CLUSTER BIOLOGICALLY SIMILAR PARTICIPANTS CUTTING ACROSS CONVENTIONAL DIAGNOSTIC BOUNDARIES TO UNDERSTAND BOTH SHARED AND DISTINCT DEVELOPMENTAL TRAJECTORIES OF BRAIN ASYMMETRY AND BEHAVIOR/COGNITION IN NDDS. OUR STUDY HAS THE POTENTIAL TO PROVIDE DEFINITIVE NEUROBIOLOGICAL MODELS OF NDDS, WITH PRACTICAL IMPLICATIONS FOR HELPING IN REFORMULATING CURRENT DIAGNOSTIC CATEGORIES OF NDDS WITH NOVEL DISORDER DEFINITIONS ROOTED IN THE BIOLOGY OF NEURODEVELOPMENT PROCESSES, AND IN IDENTIFYING PREDICTIVE BIOMARKERS FOR DIAGNOSIS AND THE RIGHT TIME WINDOW FOR PROPER INTERVENTION/TREATMENT.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 1/26/26 | ||
| Not listed | $134.9k | 3/25/25 | ||
| Not listed | $134.9k | 3/25/25 | ||
| Not listed | $28.9k | 3/21/25 | ||
| Not listed | $28.9k | 3/21/25 |
GrantNumber | Description | Subgrantee | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
SCON00006946S | Centre For Addiction And Mental Health | Project Grant R21MH133239 | $50.9k | 9/8/25 |